Global Point-of-Care Testing (POCT) Market 2025-2033
Global Point-of-Care Testing Market to Reach USD 64.9 Billion by 2033, Driven by Homecare Diagnostics, AI Integration, and Molecular Testing Advances
Phoenix Research Forecasts CAGR of ~7.0% from 2025–2033; Asia Pacific Emerges as Fastest-Growing Region
– September 15, 2025 – Phoenix Research, a leader in AI-enabled healthcare market intelligence, has released its latest report: “Global Point-of-Care Testing (POCT) Market: Decentralized Care, Molecular Innovation, and AI-Enabled Diagnostics (2025–2033).” The report projects the global POCT market to expand from USD 38.4 billion in 2025 to nearly USD 64.9 billion by 2033, reflecting a CAGR of ~7.0%.
The study highlights how portable, rapid testing solutions are transforming diagnostics across hospitals, clinics, homecare, and emergency settings—reshaping patient care through faster decision-making, reduced lab burden, and improved accessibility.
“Point-of-care testing is no longer an auxiliary tool—it’s becoming central to healthcare delivery,” said Rachna Patni, Analyst at Phoenix Research. “Our analytics show that molecular POCT, digital connectivity, and home-based self-testing will be the biggest growth drivers over the next decade, particularly in Asia Pacific.”
Key Insights from the Report
-
Rising Disease Burden: Increasing cases of diabetes, cardiovascular disorders, and infectious diseases (HIV, influenza, COVID-19) fuel adoption.
-
Decentralized & Homecare Shift: Portable POCT devices enable monitoring beyond hospitals, supporting chronic disease management at home.
-
Molecular & AI-Enabled Testing: Expansion of PCR-based rapid tests, AI-driven interpretation, and cloud connectivity enhance accuracy and scalability.
-
Healthcare Accessibility in Emerging Markets: Government-led programs and diagnostic infrastructure expansion accelerate adoption in Asia Pacific and Latin America.
-
Faster Clinical Decision-Making: Near-patient testing reduces turnaround time, improving emergency and critical care outcomes.
Regional Highlights
-
North America – Largest Market (2024): High adoption of advanced POCT devices, strong reimbursement framework, and large diabetic population.
-
Europe: Early disease detection focus and integration of molecular POCT into established healthcare systems.
-
Asia Pacific – Fastest Growing Region: Rapid healthcare investments, urbanization, and rising prevalence of chronic and infectious diseases.
-
Latin America & Middle East & Africa: Expanding primary care access and government-backed screening programs.
Competitive Landscape
Key players include Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Danaher (Cepheid), Becton Dickinson (BD), QuidelOrtho, Chembio Diagnostics, EKF Diagnostics, Bio-Rad Laboratories, and Sysmex Corporation.
Companies compete through regulatory approvals, product innovation, connected device platforms, and partnerships with healthcare providers.
Phoenix’s AI Toolkit in Action
-
Demand Forecast Engine: Models growth by product mix, chronic disease prevalence, and regional adoption.
-
Connectivity & Data Management Tracker: Monitors integration of POCT with EMRs and cloud platforms.
-
Sentiment Analyzer: Highlights consumer preference for at-home, portable testing devices.
-
Cost Efficiency Model: Quantifies POCT’s role in reducing hospitalization costs and lab burden.
Forecast Snapshot: 2025–2033
| Metric | Value |
|---|---|
| 2025 Market Size | USD 38.4 Billion |
| 2033 Market Size | ~USD 64.9 Billion |
| CAGR (2025–2033) | ~7.0% |
| Largest Region (2024) | North America |
| Fastest Growing Region | Asia Pacific |
| Top Product Segment | Blood Glucose Monitoring Kits |
| Key Trend | Molecular & AI-driven POCT |
| Future Focus | Home-based diagnostics, connectivity, molecular testing platforms |
Final Takeaway
The Global POCT Market is entering a pivotal growth phase, underpinned by disease prevalence, decentralized healthcare delivery, and technological innovation. With Asia Pacific accelerating as a high-growth region and digital connectivity redefining diagnostics, POCT is poised to become a cornerstone of modern healthcare.
Companies that invest in AI-enabled solutions, molecular testing platforms, and homecare-focused devices will capture long-term market share. Phoenix Research provides AI-driven strategic intelligence to support investment, innovation, and expansion strategies in this rapidly evolving space.
For more insights and to access the full report, visit: https://www.pheonixresearch.com/market-report/global-point-of-care-testing-market
